← Open Payments lookup

KEVIN WETHEY: Open Payments

NPI 1306378559 · DIAMOND BAR, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$801 in 39 payments from 12 companies in 2025. Trend: 2023 $68 · 2024 $476 · 2025 $801

Food & beverage: $801
CompanyPaymentsAmount
ABBVIE INC.15$254
Alkermes, Inc.5$138
Axsome Therapeutics, Inc.4$97
Otsuka America Pharmaceutical, Inc.4$84
Teva Pharmaceuticals USA, Inc.2$53
Janssen Pharmaceuticals, Inc2$40
E.R. Squibb & Sons, L.L.C.2$30
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$26
Neurocrine BioSciences, Inc.1$24
Lundbeck LLC1$24

Products named: VRAYLAR, ARISTADA, Auvelity, AUSTEDO XR, REXULTI, INVEGA SUSTENNA, ABILIFY ASIMTUFII, COBENFY.

Industry payments across CA — which companies pay providers there.